Comparison of brief cognitive tests and csf biomarkers in predicting alzheimer's disease in mild cognitive impairment: Six-year follow-up study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Palmqvist, Sebastian ^a   Hertze, Joakim ^a   Minthon, Lennart ^a   Wattmo, Carina ^a   Zetterberg, Henrik ^b   Blennow, Kaj ^b   Londos, Elisabet ^a   Hansson, Oskar ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; THREONINE;

ADULT; AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; BRAIN TUMOR; CEREBROSPINAL FLUID ANALYSIS; CLOCK DRAWING TEST; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PREVALENCE; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEMANTIC DEMENTIA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; TAU PROTEINS;

EID: 84862676596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038639     Document Type: Article

References (53)

1. Leifer BP, (2003) Early diagnosis of Alzheimer's disease: clinical and economic benefits. J Am Geriatr Soc 51: S281-288.
2. Modrego PJ, (2006) Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res 3: 161-170.
3. Carter MD, Simms GA, Weaver DF, (2010) The development of new therapeutics for Alzheimer's disease. Clin Pharmacol Ther 88: 475-486.
4. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280-292.
5. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, et al. (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
6. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement.
7. Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, et al. (2008) Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 4: 38-48.
8. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, et al. (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5: 228-234.
9. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, et al. (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302: 385-393.
10. Ismail Z, Rajji TK, Shulman KI, (2010) Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 25: 111-120.
11. Buchhave P, Stomrud E, Warkentin S, Blennow K, Minthon L, et al. (2008) Cube copying test in combination with rCBF or CSF A beta 42 predicts development of Alzheimer's disease. Dement Geriatr Cogn Disord 25: 544-552.
12. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, et al. (2000) Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55: 1847-1853.
13. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, et al. (2001) Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 58: 853-858.
14. Jungwirth S, Zehetmayer S, Bauer P, Weissgram S, Tragl KH, et al. (2009) Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm 116: 1513-1521.
15. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L, (2000) The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 57: 839-844.
16. Tierney MC, Herrmann N, Geslani DM, Szalai JP, (2003) Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's disease. J Am Geriatr Soc 51: 813-818.
17. Cui Y, Liu B, Luo S, Zhen X, Fan M, et al. (2011) Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 6: e21896.
18. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, et al. (2010) Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging.
19. Llano DA, Laforet G, Devanarayan V, (2011) Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Alzheimer Dis Assoc Disord 25: 73-84.
20. Hertze J, Minthon L, Zetterberg H, Vanmechelen E, Blennow K, et al. (2010) Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years. J Alzheimers Dis.
21. Petersen RC, (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-194.
22. American Psychiatric Association, (1987) Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev. Arlington, USA: American Psychiatric Association.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
25. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, et al. (2000) Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm pp. 23-30.
26. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, et al. (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872.
27. Folstein MF, Folstein SE, McHugh PR, (1975) "Mini-mental state" J Psychiatr Res 12: 189-198 A practical method for grading the cognitive state of patients for the clinician.
28. Small BJ, Viitanen M, Backman L, (1997) Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol A Biol Sci Med Sci 52: M299-304.
29. Shulman KI, (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15: 548-561.
30. Blennow K, Hampel H, Weiner M, Zetterberg H, (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131-144.
31. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, et al. (2005) Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem 51: 336-345.
32. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
33. Shulman KI, Gold DP, Cohen CA, Zucchero CA, (1993) Clock-drawing and dementia in the community: A longitudinal study. International Journal of Geriatric Psychiatry 8: 487-496.
34. American Psychiatric Association, (1994) Washington, DC, USA: American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (APA).
35. Jefferson AL, Cosentino SA, Ball SK, Bogdanoff B, Leopold N, et al. (2002) Errors produced on the mini-mental state examination and neuropsychological test performance in Alzheimer's disease, ischemic vascular dementia, and Parkinson's disease. J Neuropsychiatry Clin Neurosci 14: 311-320.
36. Palmqvist S, Hansson O, Minthon L, Londos E, (2009) Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests. Int J Geriatr Psychiatry 24: 1405-1412.
37. Ehreke L, Luppa M, Konig HH, Riedel-Heller SG, (2010) Is the Clock Drawing Test a screening tool for the diagnosis of mild cognitive impairment? A systematic review. Int Psychogeriatr 22: 56-63.
38. Zanetti M, Ballabio C, Abbate C, Cutaia C, Vergani C, et al. (2006) Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study. J Am Geriatr Soc 54: 580-586.
39. Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, et al. (2006) Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 12: 166-175.
40. Gnanalingham KK, Byrne EJ, Thornton A, (1996) Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 347: 696-697.
41. Libon DJ, Malamut BL, Swenson R, Sands LP, Cloud BS, (1996) Further analyses of clock drawings among demented and nondemented older subjects. Arch Clin Neuropsychol 11: 193-205.
42. Libon DJ, Swenson RA, Barnoski EJ, Sands LP, (1993) Clock drawing as an assessment tool for dementia. Arch Clin Neuropsychol 8: 405-415.
43. Mitchell AJ, (2009) CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J Neurol Neurosurg Psychiatry 80: 966-975.
44. Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, et al. (2012) Cerebrospinal Fluid Levels of beta-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia. Arch Gen Psychiatry 69: 98-106.
45. Petersen RC, (2007) Mild cognitive impairment: current research and clinical implications. Semin Neurol 27: 22-31.
46. Petersen RC, (2011) Clinical practice. Mild cognitive impairment. N Engl J Med 364: 2227-2234.
47. Hodges JR, Patterson K, (2007) Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol 6: 1004-1014.
48. Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, et al. (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124: 1438-1449.
49. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, et al. (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ 310: 970-973.
50. Zaccai J, McCracken C, Brayne C, (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34: 561-566.
51. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS, (2005) Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64: 834-841.
52. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, et al. (2006) Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 63: 674-681.
53. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA, (2009) The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 66: 200-208.